National and Kapodistrian University of Athens
Μελέτη της επίδρασης του αναστολέα ρενίνης, αλισκιρένη, στα πρόδρομα ενδοθηλιακά κύτταρα σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 και αρτηριακή υπέρταση
Abstract
dc:descriptionThe aim of the present thesis was to investigate the effects of aliskiren on endothelial progenitor cells (EPCs), endothelial function and arterial stiffness in patients with type 2 diabetes and essential hypertension. The study enrolled type 2 diabetic patients aged >50 years, under stable glycaemic control and first diagnosed mild essential hypertension. The study included two phases. In phase A, twenty patients received aliskiren 150-300 mg/daily for 3 months. Only twelve of the twenty patients proceeded in phase B, in which hydrochlorothiazide (HCTZ) 12.5-25 mg/daily substituted for aliskiren for 3 more months. At baseline and at the end of each phase, we assessed i) EPCs of peripheral blood. EPCs were determined and counted by flow cytometry and culture of mononuclear cells of peripheral blood ii) brachial blood pressure (BBP), iii) central aortic systolic pressure (CSP), central aortic pulse pressure (CPP), aortic augmentation index (Aix) and pulse wave velocity (PWV) as markers of arterial stiffness, iv) brachial artery flow-mediated dilatation (FMD) as marker of endothelial function, v) left ventricular (LV) twisting and untwisting as markers of LV diastolic function vi) thiobarbituric reactive substances (TBARS) which indicate the levels of oxidative stress vii) total plasma nitrite / nitrate concentrations as markers of NO bioavailability and viii) the cardiovascular risk markers high-sensitivity C-reactive protein (hsCRP) and lipoprotein associated phospholipase A2 (Lp-PLA2) activity. Aliskiren similarly reduced BBP and CSP, increased FMD (p<0.001) and EPCs number (p<0.001), decreased PWV and Aix (p<0.05), and improved markers of LV function. Although substitution of HCTZ sustained BBP at similar levels, CSP, CPP and echocardiographic indices returned at baseline levels. Simultaneously, the improvement of FMD, PWV, Aix and EPCs number achieved by aliskiren was abolished after treatment with HCTZ. In conclusion, aliskiren had a favorable effect on EPCs, endothelial function, arterial stiffness and improved LV function. These effects were independent of BBP lowering, as they were not observed after the achievement of similar values of BBP with HCTZ.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mazioti, Maria
- Μαζιώτη, Μαρία
Subjects
dc:subject × 18- Σακχαρώδης διαβήτης
- Αρτηριακή υπέρταση
- Αλισκιρένη
- Πρόδρομα ενδοθηλιακά κύτταρα
- Ενδοθηλιακή λειτουργία
- Αρτηριακή σκληρία
- Diabetes mellitus
- Hypertension
- Aliskiren
- Endothelial progenitor cells
- Endothelial function
- Arterial stiffness
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41717